Congratulations to Professor Dario Campana (Department of Paediatrics) who was conferred the prestigious Gabbay award for his groundbreaking CAR-T cell immunotherapy work. He is one of two researchers conferred the international Jacob and Louise Gabbay Award in Biotechnology and Medicine, which recognises scientists in academia, medicine or industry whose work hold outstanding scientific content and significant practical consequences in the biomedical sciences.
Prof Campana is one of the pioneers of the CAR-T cell therapy, which has been recently used to successfully treat children and adults with Acute Lymphoblastic Leukemia (ALL) here in Singapore at the National University Hospital (NUH).
“I am pleased that the Gabbay committee identified CAR-T cells for recognition this year, and am honoured to be a recipient of the award together with Dr. Sadelain. CAR-T cell therapy is having a dramatic impact on ALL treatment; we are currently working hard to improve this technology to extend it to other forms of cancer,” said Prof Campana.
Bringing Hope to Cancer Patients
The 10 patients, aged between four and 28, who were treated using this CAR-T immunotherapy are responding well to the treatment. Other standard treatment for ALL (e.g. chemotherapy and bone marrow transplants) were not working effectively for these patients previously.
“Prof Campana’s work brings hope to cancer patients,” said Associate Professor Allen Yeoh. “For the first time, without needing to go to the USA, Singaporeans with relapsed/resistant ALL that was previously considered incurable can now receive such life-saving treatment in Singapore.”
Assoc Prof Yeoh added, “We are glad to be able to provide compassionate CAR-T cell therapy for Singapore and ASEAN children with relapsed/resistant ALL. Alongside Prof Campana’s team, we hope to start CAR-T cell therapy trials in January 2020 for children and adults with high risk and relapsed/resistant ALL.”
The expanded trial is expected to involve about 100 patients over a period of five to 10 years; and will also examine other ways in which the CAR could be used to treat other forms of leukemia and cancers.
Read the press release here.
- Channel 5, News 5, 31 July 2019 (21:08 - 23:32)
- Channel 8, News Tonight, 31 July 2019 (20:21 - 21:50)
- Channel NewsAsia, Singapore Tonight, 31 July 2019 (08:32 - 10:59)
- Suria, Berita, 31 July 2019 (08:57 - 10:34)
- "Patients resistant to chemotherapy found to respond to immunotherapy; trials to begin in January", The Straits Times, 31 July 2019, Online
- "治疗血癌教授获奖", Lianhe Zaobao, 31 July 2019, Online
- Warna 94.2FM, 31 July 2019
- "Cellular therapy gives hope to cancer patients", The Straits Times, 1 August 2019, pB3
- "NUS Medicine researcher wins Gabbay award for CAR-T Immunotherapy", BioSpectrum Asia, 1 August 2019, Online
- "10名年幼病患康复良好 研究免疫疗法治愈血癌国大教授获奖", Lianhe Zaobao, 24 August 2019, Online